June 12, 2018 / 4:12 AM / in 2 months

BUZZ-India's Strides Shasun rises on US FDA nod for flu treatment

** Shares of Strides Shasun Ltd climb as much as 5.5 pct to 369 rupees

** The drugmaker said on Monday here its unit Strides Pharma Global received final approval from the U.S. Food and Drug Administration for oseltamivir phosphate capsules, a treatment for symptoms caused by influenza

** The drug will be marketed by Strides Pharma Inc in the U.S. market

** Over 2.6 mln shares have changed hands vs. the 30-day moving avg of 4.7 mln

** Up to Monday’s close, stock had lost more than half its value this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below